Ordinary Re-Weighting | Solactive Europe & US Top Pharmaceuticals 2020 AR 3.5% Index | Effective Date 6th January 2025
Solactive Europe & US Top Pharmaceuticals 2020 AR 3.5% Index:
In the ordinary re-weighting, the following composition will be implemented effective open 6th January 2025:
| ABBVIE INC |
| ASTRAZENECA PLC |
| BRISTOL-MYERS SQUIBB CO |
| JOHNSON & JOHNSON |
| MERCK & CO. INC. |
| NOVARTIS AG |
| NOVO NORDISK A/S |
| PFIZER INC |
| ROCHE HOLDING AG |
| SANOFI SA |